Gorordo-Delsol LA, Zamora-Gómez SE, Hernández-López GD, García-Román MTA, Jiménez-Ruiz A, Tercero-Guevara BI

Idioma: Español
Referencias bibliográficas: 44
Paginas: 105-113
Archivo PDF: 164.13 Kb.

RESUMEN

La tromboembolia pulmonar aguda es una patología que en México y en todo el mundo se registra entre 20 a 30% de los resultados de necropsia; sin embargo, la proporción del diagnóstico realizado en pacientes vivos es menor de 10%; un gran acúmulo de información aparece cada año acerca de predictores clínicos, herramientas de diagnóstico, métodos y fármacos para manejo agudo y crónico. En el presente trabajo se realizó una revisión sistemática de las bases de datos internacionales de los últimos 10 años, seleccionando las publicaciones de mayor impacto, complementando con artículos de relevancia y las nuevas guías publicadas en Europa (2014). El documento está organizado en siete secciones: introducción, metodología, epidemiología, manifestaciones clínicas y abordaje diagnóstico, severidad, manejo agudo y manejo crónico, permitiendo al lector sistematizar la información, que se suma en dos algoritmos de manejo (embolia pulmonar estable e inestable).

REFERENCIAS (EN ESTE ARTÍCULO)

1. Wood KE. The history of pulmonary embolism and deep venous thrombosis. Crit Care Clin 2009; 25: 115-31.

2. Jiménez D, Uresandi F. Consenso intersociedades español sobre el diagnóstico, estratificación de riesgo y tratamiento de pacientes con tromboembolia pulmonar. Angiol 2014; 66(2): 70-84.

3. Pulido T, Aranda A, Zeballos MA, Bautista E, Martínez–Guerra ML, Santos LE, et al. Pulmonary embolism as a cause of death inpatients with heart disease. An Autopsy Study. Chest 2006; 129: 1282-7.

4. Ageno W. The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J Throm Haemos 2013; 11: 1597-602.

5. Torbicki A y col. Guías de práctica clínica de la Sociedad Europea de Cardiología sobre diagnóstico y manejo del tromboembolismo pulmonar agudo. Rev Esp Cardiol 2008; 61(12): 1330; e1-1330.e52.

6. Torbicki A y col. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2008, 19: 2276-315.

7. Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann Intern Med 2001; 135(2): 98-107.

8. Le Gal G, Righini M, Roy PM, Sánchez O, Aujesky D, Bounameaux H, Perrier A. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 2006; 144(3): 165-171.

9. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172(8): 1041-6.

10. Venetz C, Jiménez D, Méan M, Aujesky D. A comparison of the original and simplified Pulmonary Embolism Severity Index. Thromb Haemost 2011; 106: 423-8.

11. Youssf ARI, Ismail MFM, ElGhamry R, Reyad MR. Diagnostic accuracy of D-dimer assay in suspectec pulmonary embolism patients. Egyp J Chest Dis Tuber 2014; 64: 411-417.

12. Lindner F. y col. D-dimer to rule out pulmonary embolism in renal insufficiency. AM J MED 2014, 127:343-347

13. Schouten HJ, Geersing GJ, Koek HL, Zuithoff NP, Janssen KJ, Douma RA, van Delden JJ, Moons KG, Reitsma JB. Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis. BMJ 2013; 346: f2492.

14. Krivak T, Zorn KK. Venous thromboembolism in obstetrics and gynecology. Obstet Gynecol 2007; 109: 761-77.

15. Kline JA, Williams GW, Hernández-Nino J. D-Dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clinical Chemistry 2005; 51(5): 825-9.

16. Jeremiah ZA, Adias TC, Opia M, George SP, Mgbere O, Essien EJ. Elevation in D-dimer concentrations is positively correlated with gestation in normal uncoplicated pregnancy. International Journal of Women’s Health 2012; 4: 437-43.

17. Jaff MR, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123: 1788-830.

18. McConnell MV, Salomon SD, Rayan ME, et al. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996; 78: 469-73.

19. Lichtenstein D, Mezière GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: The BLUE Protocol. Chest 2008; 134: 117-25.

20. Kuriakose J, Patel S. Acute pulmonary embolism. Radiol Clin N Am 2010; 48: 31-50.

21. Öskan H, et al. A novel method for pulmonary embolism detection in CTA images. Com Meth Prog Biomed 2014; 113: 757-66.

22. Morales J, Rosas M, Campos R, Becerra J. Proceso diagnóstico de la tromboembolia pulmonar. Neumol Cir Torax 2013; 72(4): 323-32.

23. The PISAPED Investigators. Invasive and noninvasive diagnosis of pulmonary embolism. Preliminary results of the prospective investigative study of acute pulmonary embolism diagnosis (PISAPED). Chest 1995; 107(Suppl. 1): S33-S38.

24. Stein P, Gottschalk A, Sostman HD, Chenevert TL, Fowler SA, Goodman LR, et al. Methods of prospective investigation of pulmonary embolism diagnosis III (PIOPED III). Semin Nucl Med 2008; 38(6): 462-70.

25. Stein P, Gottschalk A, Sostman HD, Chenevert TL, Fowler SA, Goodman LR, et al. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism (PIOPED III). Ann Intern Med 2010; 152(7): 434-43.

26. Meyer G, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Eng J Med 2014; 370: 1402-11.

27. Chatterjee S, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, mayor bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 2014; 311(23): 2414-21.

28. PIOPED Investigators. Tissue plasminogen activator for the treatment of acute pulmonary embolism: a collaborative study by the PIOPED Investigators. Chest 1990; 97(3): 528-33.

29. Becattini C, Agnelli G, Salvi A, et al; TIPES Study Group. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res 2010; 125(3): e82-e86.

30. SharifiM, Bay C, Skrocki L, Rahimi F, Mehdipour M; “MOPETT” Investigators. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol 2013; 111(2): 273-277.

31. Kucher N, Boekstegers P, Müller OJ, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014; 129(4): 479-86.

32. Kline JA, Nordenholz KE, Courtney DM, et al. Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost 2014; 12(4): 459-68.

33. Muriel A, Jiménez D, Aujesky D, et al. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk. J Am Coll Cardiol 2014; 63(16): 1675-83.

34. Stein PD, Matta F. Vena cava filters in unstable elderly patients with acute pulmonary embolism. Am J Med 2014; 127: 222-5.

35. Kuo WT. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and metaanalysis of modern techniques. J Vasc Interv Radiol 2009; 20(11): 1431-40.

36. The EINSTEIN-PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Eng J Med 2012; 366: 1287-97.

37. Shulman S, et al. Extended use of dabigatran, warfarin or placebo in venous thromboembolism. N Eng J Med 2013; 368: 709-18.

38. Agnelli G, et al. Oral Apixaban for the treatment of acute venous thromboembolism. N Eng J Med 2013; 369(9): 799- 808.

39. Agnelli G, et al. Apixaban for extended treatment of venous thromboembolism. N Eng J Med 2013; 368: 699-708.

40. Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, et al. Aspirin for preventing the recurrence of venous thromboembolism. N Eng J Med 2012; 366: 1959-67.

41. Castellucci LA, Cameron C, LeGal G, Rodger MA, Doyle D, Wells PS, et al. Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. BMJ 2013; 347: f5133.

42. Aujesky D, Roy PM, Vershuren F, et al. Outpatient versus inpatient treatment fot patients with acute pulmonary embolism: an international, open-label, randomized, noninferiority trail. The Lancet 2011; 378(9785): 41-8.

43. Becattini C, Agnelli G, Vedovati MC, Pruszczyk P, Casazza F, Grifoni S, Salvi A, et al. Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur Heart J 2011; 32(13): 1657-63.

44. Konstantinides S, et al. ESC Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology. Eur Heart J 2014. Doi:10.1093/eurheartj/ehu283.